Yoshihiro Arai
Algemeen Directeur bij SOLASIA PHARMA K.K.
Vermogen: 190 754 $ op 30-04-2024
Actieve functies van Yoshihiro Arai
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SOLASIA PHARMA K.K. | Directeur/Bestuurslid | 01-02-2013 | - |
Algemeen Directeur | 01-02-2013 | - | |
President | 01-02-2013 | - | |
Corporate Officer/Principal | 01-09-2007 | 01-02-2013 |
Loopbaan van Yoshihiro Arai
Eerdere bekende functies van Yoshihiro Arai
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Searle Yakuhin KK | Corporate Officer/Principal | - | - |
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Corporate Officer/Principal | - | - |
Opleiding van Yoshihiro Arai
University of Wales (Bangor) | Masters Business Admin |
Tokyo University of Pharmacy & Life Science | Graduate Degree |
Statistieken
Internationaal
Japan | 5 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SOLASIA PHARMA K.K. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
Searle Yakuhin KK |
- Beurs
- Insiders
- Yoshihiro Arai
- Ervaring